These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
301 related articles for article (PubMed ID: 16905950)
1. Effect of phosphatidylcholine, phosphatidylethanolamine and lysophosphatidylcholine on the activated factor X-prothrombin system. Tsuda T; Yoshimura H; Hamasaki N Blood Coagul Fibrinolysis; 2006 Sep; 17(6):465-9. PubMed ID: 16905950 [TBL] [Abstract][Full Text] [Related]
2. Effect of phosphatidylcholine, phosphatidylethanolamine and lysophosphatidylcholine on the protein C/protein S anticoagulation system. Tsuda T; Yoshimura H; Hamasaki N Blood Coagul Fibrinolysis; 2006 Sep; 17(6):453-8. PubMed ID: 16905948 [TBL] [Abstract][Full Text] [Related]
3. The effect of membrane composition on the hemostatic balance. Smirnov MD; Ford DA; Esmon CT; Esmon NL Biochemistry; 1999 Mar; 38(12):3591-8. PubMed ID: 10090745 [TBL] [Abstract][Full Text] [Related]
4. Determinants of the formation and activity of factor V-phospholipid complexes. II. Molecular properties of the complexes. Kandall CL; Shohet SB; Akinbami TK; Colman RW Thromb Diath Haemorrh; 1975 Sep; 34(1):271-84. PubMed ID: 1188712 [TBL] [Abstract][Full Text] [Related]
5. Adsorption of vitamin K-dependent blood coagulation proteins to spread phospholipid monolayers as determined from combined measurements of the surface pressure and surface protein concentration. Ellison EH; Castellino FJ Biochemistry; 1998 Jun; 37(22):7997-8003. PubMed ID: 9609692 [TBL] [Abstract][Full Text] [Related]
13. Decreased serum level of tumor necrosis factor in animals treated with lipopolysaccharide and liposomes containing phosphatidylserine. Monastra G; Bruni A Lymphokine Cytokine Res; 1992 Feb; 11(1):39-43. PubMed ID: 1576245 [TBL] [Abstract][Full Text] [Related]
14. Reactions of activated factor X-phosphatide mixtures in vitro and in vivo. Barton PG; Yin ET; Wessler S J Lipid Res; 1970 Mar; 11(2):87-95. PubMed ID: 5418483 [TBL] [Abstract][Full Text] [Related]
15. Activated coagulation factors in human malignant effusions and their contribution to cancer cell metastasis and therapy. Gieseler F; Lühr I; Kunze T; Mundhenke C; Maass N; Erhart T; Denker M; Beckmann D; Tiemann M; Schulte C; Dohrmann P; Cavaillé F; Godeau F; Gespach C Thromb Haemost; 2007 Jun; 97(6):1023-30. PubMed ID: 17549306 [TBL] [Abstract][Full Text] [Related]
16. Monoclonal immunoglobulin M lambda coagulation inhibitor with phospholipid specificity. Mechanism of a lupus anticoagulant. Thiagarajan P; Shapiro SS; De Marco L J Clin Invest; 1980 Sep; 66(3):397-405. PubMed ID: 6772673 [TBL] [Abstract][Full Text] [Related]
18. Membrane-dependent coagulation reaction is independent of the concentration of phospholipid-bound substrate: fluid phase factor X regulates the extrinsic system. Forman SD; Nemerson Y Proc Natl Acad Sci U S A; 1986 Jul; 83(13):4675-9. PubMed ID: 3487782 [TBL] [Abstract][Full Text] [Related]
19. Interaction of short chain and long chain fatty acid phosphoglycerides and bile salts with prothrombin. Bajwa SS; Hanahan DJ Biochim Biophys Acta; 1976 Aug; 444(1):118-30. PubMed ID: 986183 [TBL] [Abstract][Full Text] [Related]
20. Effect of thyrotropin on phospholipid composition in thyroid plasma membranes. Stelmach H; Mośko P; Jaroszewicz L J Physiol Pharmacol; 1993 Jun; 44(2):179-83. PubMed ID: 8358054 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]